PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567140
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1567140
The Global PET-CT Scanner Device Market is estimated to be valued at USD 2.31 Billion in 2024 and is expected to reach USD 3.45 Billion by 2031, exhibiting a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 2.31 Bn |
Historical Data for: | 2019 To 2023 | Forecast Period: | 2024 To 2031 |
Forecast Period 2024 to 2031 CAGR: | 5.90% | 2031 Value Projection: | US$ 3.45 Bn |
PET-CT scanner device market has been witnessing a significant growth over the past few years owing to increasing prevalence of cancer and other chronic diseases globally. PET-CT scanner combines two medical imaging techniques- positron emission tomography and X-ray computed tomography into a single device, allowing physicians to obtain functional and anatomical information simultaneously. Some of the key advantages of PET-CT over other imaging modalities include better detection of tumors, evaluation of cancer treatment response and localization of sites of metastases. Growing geriatric population prone to various forms of cancers as well as increasing awareness about early disease diagnosis have been fueling the demand for PET-CT scanners across major healthcare markets. However, high equipment and radiotracer production costs pose a major barrier to widespread adoption.
The global PET-CT scanner device market is driven by rising cancer incidence, increasing public-private investments to enhance diagnostic imaging facilities and favorable reimbursement scenario for PET-CT procedures in developed nations. As per WHO, cancer burden is expected to surge by over 70% in next two decades. This widespread cancer epidemic is anticipated to augment the market growth during the forecast period. However, market potential can be negatively impacted by certain factors such as radiation exposure risks, shortage of trained professionals and high monetary investments required for setting up PET-CT production units. Market players could gain new opportunities from emerging therapeutic applications of PET-CT including treatment monitoring and drug development. Technology advancements in radiotracer development, hybrid scanner design and image reconstruction software are also expected to open new revenue streams for market participants going forward.
This report provides in-depth analysis of the global PET-CT scanner device market and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global PET-CT scanner device market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include GE Healthcare, Siemens Healthineers, Koninklijke Philips N.V., Canon Inc. and Fujifilm Holdings Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global PET-CT scanner device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global PET-CT scanner device market.
Detailed Segmentation-